We are live on ! Find out more
BIOSU

BioPlus Acquisition Corp. Unit
BIOSU

Delisted

BIOSU was delisted on the 6th of October, 2023.

Back to rankings

80 hedge funds and large institutions have $220M invested in BioPlus Acquisition Corp. Unit in 2021 Q4 according to their latest regulatory filings, with 80 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
+80
Holders Change %
–
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
80
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Saba Capital Management
New York
+$15M
2
HCM
Highbridge Capital Management
New York
+$10.8M
3
Calamos Advisors
Calamos Advisors
Illinois
+$10M
4
LA
Linden Advisors
New York
+$10M
5
Goldman Sachs
Goldman Sachs
New York
+$8.61M

Top Sellers

No sellers this quarter

BIOSU Hedge Fund Activity: Q4 2021 in Review

80 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Unit (BIOSU) for Q4 2021, worth a combined $220M.

Buyers outnumbered sellers: 80 funds opened new BIOSU positions and 0 closed out — a net gain of 80 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Saba Capital Management, opening a new position worth an estimated $15M.

  • 80 institutional investors held BioPlus Acquisition Corp. Unit (BIOSU) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $220M of BioPlus Acquisition Corp. Unit stock for Q4 2021.
  • 80 funds opened new BioPlus Acquisition Corp. Unit positions in Q4 2021 and 0 closed out, a net change of +80 holders.
  • The largest BioPlus Acquisition Corp. Unit buyer in Q4 2021 was Saba Capital Management, an estimated $15M added.

Based on aggregated 13F filings for Q4 2021.